Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Apixaban metabolism and pharmacokinetics after oral administration to humans. [electronic resource] by
- Raghavan, Nirmala
- Frost, Charles E
- Yu, Zhigang
- He, Kan
- Zhang, Haiying
- Humphreys, W Griffith
- Pinto, Donald
- Chen, Shiangyuan
- Bonacorsi, Samuel
- Wong, Pancras C
- Zhang, Donglu
Producer: 20090302
In:
Drug metabolism and disposition: the biological fate of chemicals vol. 37
Availability: No items available.
|
|
12.
|
|
|
13.
|
Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moieties. [electronic resource] by
- Orwat, Michael J
- Qiao, Jennifer X
- He, Kan
- Rendina, Alan R
- Luettgen, Joseph M
- Rossi, Karen A
- Xin, Baomin
- Knabb, Robert M
- Wexler, Ruth R
- Lam, Patrick Y S
- Pinto, Donald J P
Producer: 20150305
In:
Bioorganic & medicinal chemistry letters vol. 24
Availability: No items available.
|
|
14.
|
Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor. [electronic resource] by
- He, Kan
- Luettgen, Joseph M
- Zhang, Donglu
- He, Bing
- Grace, James E
- Xin, Baomin
- Pinto, Donald J P
- Wong, Pancras C
- Knabb, Robert M
- Lam, Patrick Y S
- Wexler, Ruth R
- Grossman, Scott J
Producer: 20111213
In:
European journal of drug metabolism and pharmacokinetics vol. 36
Availability: No items available.
|
|
15.
|
Phenyltriazolinones as potent factor Xa inhibitors. [electronic resource] by
- Quan, Mimi L
- Pinto, Donald J P
- Rossi, Karen A
- Sheriff, Steven
- Alexander, Richard S
- Amparo, Eugene
- Kish, Kevin
- Knabb, Robert M
- Luettgen, Joseph M
- Morin, Paul
- Smallwood, Angela
- Woerner, Francis J
- Wexler, Ruth R
Producer: 20100602
In:
Bioorganic & medicinal chemistry letters vol. 20
Availability: No items available.
|
|
16.
|
Pyrazole-based factor Xa inhibitors containing N-arylpiperidinyl P4 residues. [electronic resource] by
- Qiao, Jennifer X
- Cheng, Xuhong
- Smallheer, Joanne M
- Galemmo, Robert A
- Drummond, Spencer
- Pinto, Donald J P
- Cheney, Daniel L
- He, Kan
- Wong, Pancras C
- Luettgen, Joseph M
- Knabb, Robert M
- Wexler, Ruth R
- Lam, Patrick Y S
Producer: 20070515
In:
Bioorganic & medicinal chemistry letters vol. 17
Availability: No items available.
|
|
17.
|
Structure-activity relationship and pharmacokinetic profile of 5-ketopyrazole factor Xa inhibitors. [electronic resource] by
- Varnes, Jeffrey G
- Wacker, Dean A
- Pinto, Donald J P
- Orwat, Michael J
- Theroff, Jay P
- Wells, Brian
- Galemo, Robert A
- Luettgen, Joseph M
- Knabb, Robert M
- Bai, Steven
- He, Kan
- Lam, Patrick Y S
- Wexler, Ruth R
Producer: 20080527
In:
Bioorganic & medicinal chemistry letters vol. 18
Availability: No items available.
|
|
18.
|
Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa. [electronic resource] by
- Pinto, Donald J P
- Orwat, Michael J
- Koch, Stephanie
- Rossi, Karen A
- Alexander, Richard S
- Smallwood, Angela
- Wong, Pancras C
- Rendina, Alan R
- Luettgen, Joseph M
- Knabb, Robert M
- He, Kan
- Xin, Baomin
- Wexler, Ruth R
- Lam, Patrick Y S
Producer: 20071206
In:
Journal of medicinal chemistry vol. 50
Availability: No items available.
|
|
19.
|
Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker. [electronic resource] by
- Corte, James R
- Fang, Tianan
- Osuna, Honey
- Pinto, Donald J P
- Rossi, Karen A
- Myers, Joseph E
- Sheriff, Steven
- Lou, Zhen
- Zheng, Joanna J
- Harper, Timothy W
- Bozarth, Jeffrey M
- Wu, Yiming
- Luettgen, Joseph M
- Seiffert, Dietmar A
- Decicco, Carl P
- Wexler, Ruth R
- Quan, Mimi L
Producer: 20170706
In:
Journal of medicinal chemistry vol. 60
Availability: No items available.
|
|
20.
|
Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor. [electronic resource] by
- Quan, Mimi L
- Lam, Patrick Y S
- Han, Qi
- Pinto, Donald J P
- He, Ming Y
- Li, Renhua
- Ellis, Christopher D
- Clark, Charles G
- Teleha, Christopher A
- Sun, Jung-Hui
- Alexander, Richard S
- Bai, Steve
- Luettgen, Joseph M
- Knabb, Robert M
- Wong, Pancras C
- Wexler, Ruth R
Producer: 20050503
In:
Journal of medicinal chemistry vol. 48
Availability: No items available.
|